API Group ends sale process and warns on full year results

Shares in API Group tumbled on Wednesday after the company reported that its full year results are likely to be marginally below previous management expectations, which came as a double blow as the group announced has opted not to go ahead with the anticipated sale of the company.

Shares in API Group tumbled on Wednesday after the company reported that its full year results are likely to be marginally below previous management expectations, which came as a double blow as the group announced has opted not to go ahead with the anticipated sale of the company.

The drop in full year results is primarily a result of a continued weak performance in the Holographics division.

The company revealed it had concluded that a sale of the group at this time as it is "unlikely to gain sufficient recognition for the underlying value of the business or to deliver best value for shareholders", and as a result, it has "decided to terminate the formal sale process with immediate effect".

In a statement API said: "The board remains focused on maximising shareholder value and committed to maintaining an open dialogue with shareholders about how best that can be achieved."

The firm was keen to stress that its results for the current financial year (ending March 31st) will demonstrate substantial year-on-year improvement, due to "excellent" progress at Foils Americas, Foils Europe and Laminates.

However, it admitted the outlook for both Holographics and Laminates is now "less than favourable", saying that within the latter the favourable impact on volumes for next year will be mitigated by some recent losses on other supply positions.

"The board remains confident that the group will make further progress in the year ahead," it said.

The share price had fallen 23.55% to 52.75p by 08:45 on Wednesday.

NR

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022